RegentAtlantic Capital’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$832K Sell
24,844
-5,280
-18% -$192K 0.02% 348
2022
Q2
$970K Buy
30,124
+1,106
+4% +$38.5K 0.03% 327
2022
Q1
$1.09M Buy
29,018
+3,878
+15% +$150K 0.03% 305
2021
Q4
$1.1M Buy
25,140
+3,806
+18% +$154K 0.03% 310
2021
Q3
$781K Buy
21,334
+5,662
+36% +$208K 0.02% 344
2021
Q2
$536K Buy
+15,672
New +$529K 0.02% 408
2015
Q1
Sell
-36
Closed -$939 391
2014
Q4
$939 Buy
+36
New +$461 ﹤0.01% 1187

Other funds holding APH

RegentAtlantic Capital's APH Position: Q3 2022 in Review

RegentAtlantic Capital reduced its Amphenol (APH) stake by 18% in Q3 2022, selling an estimated $192K and leaving 24,844 shares worth $832K. The position accounts for 0.02% of the portfolio, ranked #348.

RegentAtlantic Capital first reported a position in APH in Q4 2014 and has held it in 7 quarters since. The position peaked at $1.1M in Q4 2021. 910 funds tracked by Wall St. Rank hold APH as of Q3 2022.

  • RegentAtlantic Capital held 24,844 shares of Amphenol worth $832K as of Q3 2022.
  • RegentAtlantic Capital sold 5,280 Amphenol shares in Q3 2022, an estimated $192K.
  • Amphenol made up 0.02% of RegentAtlantic Capital's portfolio in Q3 2022, its #348 holding.
  • RegentAtlantic Capital first reported a position in Amphenol in Q4 2014 and has held it in 7 quarters since.
  • RegentAtlantic Capital's Amphenol position peaked at $1.1M in Q4 2021.
  • 910 funds tracked by Wall St. Rank held Amphenol as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.